Irritant Contact Dermatitis
📧 Sign up to get email alerts when something new happens for Irritant Contact Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Use of a β-Glucan Cream in Incontinence-Associated Dermatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a beta-glucan cream for incontinence-associated dermatitis in people with fecal and urinary inconti…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Glycyrrhetinic Acid and Acute Irritant Dermatitis [NA]
Clinical trial update on glycyrrhetinic acid for irritant contact dermatitis, currently not recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Moisture-associated Skin Damage in Hospitals [NA]
A clinical trial is evaluating the effectiveness of 3M Cavilon Advanced Skin Protectant for moisture-associated skin damage in hospitalized …
-
FDA approval · 2023-11-29FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for clobetasol propionate, a potent topical corticosteroid, enabling an approved supplement…
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: EpiCeram for Skin Protection in Healthcare Workers [NA]
A terminated clinical trial evaluated EpiCeram for protection against irritant contact dermatitis in healthcare workers; results were posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-12-18FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved an original application for Betamethasone dipropionate by Lupin Pharmaceuticals, Inc., granting a generic topical corticosteroi…
-
FDA approval · 2018-03-26FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a generic clobetasol propionate topical product from Glenmark Pharmaceuticals (ANDA 209004) for treatment of inflammatory and p…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence
A completed ICU-focused clinical trial identifies risk factors for developing incontinence-associated dermatitis in patients with fecal inco…
-
CLINICAL_TRIALS research · 2017-01-09Clinical Trial Update: Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity [NA]
A clinical trial update describing safety dermatological assessments of a topical dressings product to evaluate photoirritation and dermal p…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly [NA]
This clinical trial compared wash wipes with standard care for preventing incontinence-associated dermatitis in elderly individuals. The stu…
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment [NA]
A completed clinical trial evaluated the efficacy and safety of a Biocellulose Mask containing the anti-hyperpigmentation agent Farhorm for …